- 
    Has This Child Experienced Physical Abuse? JAMA (IF 55.0) Pub Date : 2025-04-21 Sonal N. Shah, Hiu-fai Fong, Suzanne B. Haney, Nancy S. Harper, Mary Clyde Pierce, Mark I. Neuman
ImportanceNearly 100 000 children experience physical abuse each year in the US. Among approximately 2000 annual deaths related to child maltreatment, more than 40% resulted from physical abuse, and half of those children were younger than 1 year. Many of these young children had unidentified abusive injuries before the fatal event.ObjectiveTo determine the accuracy of clinical and radiologic findings
 - 
    Observations on the Discovery of Glucagon-Like Peptide-1 Action JAMA (IF 55.0) Pub Date : 2025-04-21 Jacques Philippe, Alvin C. Powers
This Viewpoint offers an account of the events surrounding the discovery of the biological action of glucagon-like peptide-1 and the roles of the individuals who contributed to the discovery.
 - 
    Transforming treatment paradigms: Focus on personalized medicine for high-grade serous ovarian cancer CA: Cancer J. Clin. (IF 232.4) Pub Date : 2025-04-19 Pawel Kordowitzki, Britta Lange, Kevin M. Elias, Marcia C. Haigis, Sylvia Mechsner, Ioana Elena Braicu, Jalid Sehouli
High-grade serous ovarian cancer (HGSOC) is the most common and aggressive subtype of ovarian cancer, accounting for approximately 70% of all ovarian cancer cases and contributing significantly to the high mortality rates associated with this disease. Because of the asymptomatic nature of early stage disease, most patients are diagnosed at advanced stages when the cancer has already spread into the
 - 
    Helmholtz Health task force to strengthen prevention research and its translation globally Nat. Med. (IF 50.0) Pub Date : 2025-04-18
Prevention research aims to understand, mitigate and ultimately avert the onset and progression of disease and the spillover of pathogens. Such research includes the analysis of risk factors and fundamental mechanisms of disease emergence, early detection and screening, stratification into risk groups, and the development and evaluation of preventive interventions. In the face of population aging and
 - 
    
 - 
    Association between plausible genetic factors and weight loss from GLP1-RA and bariatric surgery Nat. Med. (IF 50.0) Pub Date : 2025-04-18 Jakob German, Mattia Cordioli, Veronica Tozzo, Sarah Urbut, Kadri Arumäe, Roelof A. J. Smit, Jiwoo Lee, Josephine H. Li, Adrian Janucik, Yi Ding, Akintunde Akinkuolie, Henrike O. Heyne, Andrea Eoli, Chadi Saad, Yasser Al-Sarraj, Rania Abdel-latif, Shaban Mohammed, Moza Al Hail, Alexandra Barry, Zhe Wang, Tatiana Cajuso, Andrea Corbetta, Pradeep Natarajan, Samuli Ripatti, Anthony Philippakis, Lukasz
 - 
    BCMA-CAR T-cells in a patient with relapsing idiopathic inflammatory myositis after CD19-CAR T-cells Nat. Med. (IF 50.0) Pub Date : 2025-04-17 Fabian Müller, Andreas Wirsching, Melanie Hagen, Simon Völkl, Carlo Tur, Maria Gabriella Raimondo, Jule Taubmann, Laura Bucci, Liang Zhang, Sascha Kretschmann, Michael Aigner, Markus Eckstein, Silvia Spörl, Soraya Kharboutli, Sebastian Böltz, Armin Atzinger, Luis Munoz, Georg Schett, Andreas Mackensen, Ricardo Grieshaber-Bouyer
CD19 chimeric antigen receptor (CD19-CAR) T-cell therapy has been shown to induce stable drug-free remission in patients with refractory autoimmune disease. The management of potential relapses is currently unclear. Here, we report on a 45-year-old woman with treatment-refractory Jo-1-associated anti-synthetase syndrome, who initially achieved disease remission after CD19-CAR T-cell therapy but then
 - 
    "Broken Heart Syndrome" Tied to High Rehospitalization Rates. JAMA (IF 55.0) Pub Date : 2025-05-20 Samantha Anderer
 - 
    New Tinnitus Guideline Offers Recommendations to Improve Patient Care. JAMA (IF 55.0) Pub Date : 2025-05-20 Samantha Anderer
 - 
    Automated Insulin Delivery May Benefit Patients With Type 2 Diabetes. JAMA (IF 55.0) Pub Date : 2025-05-20 Samantha Anderer
 - 
    Prescription Stimulant Misuse Affects About 1 in 4 Users. JAMA (IF 55.0) Pub Date : 2025-05-20 Samantha Anderer
 - 
    Measles Cases in European Region Highest in More Than 25 Years. JAMA (IF 55.0) Pub Date : 2025-05-20 Samantha Anderer
 - 
    CDC Provides New Resources for Dengue Amid Ongoing Risk. JAMA (IF 55.0) Pub Date : 2025-05-20 Samantha Anderer
 - 
    Relieve the suffering: palliative care for the next decade Lancet (IF 88.5) Pub Date : 2025-04-18 William E Rosa, Stephen Connor, Ghauri Aggarwal, Samy Alsirafy, Joanne Brennan, Helena Davies, Julia Downing, Betty Ferrell, Richard Harding, Felicia Marie Knaul, Emmanuel B K Luyirika, María M Marroquín, Joan Marston, Lukas Radbruch, M R Rajagopal, Libby Sallnow, Eric L Krakauer
No Abstract
 - 
    Diabetic Retinopathy Is Massively Underscreened—an AI System Could Help JAMA (IF 55.0) Pub Date : 2025-04-18 Roy Perlis, Kate Schweitzer
This Medical News article is an interview with Arthur Brant, MD, and Sunny Virmani, MS, about their recent research on AI screening for diabetic retinopathy in large-scale clinical settings in India.
 - 
    What Insights Into LDL Cholesterol’s Structure Could Mean for Patients JAMA (IF 55.0) Pub Date : 2025-04-18 Jennifer Abbasi
This Medical News article discusses recent landmark work to visualize the structure of the cholesterol-carrying low-density lipoprotein (LDL) particle bound to its cell surface receptor.
 - 
    Experts Say Abrupt and “Staggering” CDC Cuts Will Cost Lives JAMA (IF 55.0) Pub Date : 2025-04-18 Rita Rubin
This Medical News article discusses how recent workforce and program reductions at the US Centers for Disease Control and Prevention will affect public health.
 - 
    Using AI to screen for opioid use disorder Nat. Med. (IF 50.0) Pub Date : 2025-04-17 Louisa Picco, Suzanne Nielsen
An AI-driven screener for opioid use disorder in hospital settings could increase referrals to addiction services and improve patient outcomes, but it is crucial that treatment is accessible and that unintended harms such as stigma are avoided.
 - 
    Anti-amyloid could help prevent genetic form of Alzheimer’s disease Nat. Med. (IF 50.0) Pub Date : 2025-04-17
Despite a negative primary outcome, a trial of gantenerumab showed a clinically meaningful slowing of disease onset in asymptomatic people who were treated for the longest duration.
 - 
    Author Correction: Mpox poses an ever-increasing epidemic and pandemic risk Nat. Med. (IF 50.0) Pub Date : 2025-04-16 Carlos Maluquer de Motes, David O. Ulaeto
Correction to: Nature Medicine https://doi.org/10.1038/s41591-025-03589-8, published online 1 April 2025.
 - 
    Firearm availability and firearm incidents: quasi-experimental analysis using start of US hunting seasons BMJ (IF 42.7) Pub Date : 2025-04-16 Christopher M Worsham, Charles F Bray, Anupam B Jena
Objective To take advantage of the arbitrarily timed increase in firearm and ammunition availability brought on by the start of deer hunting seasons to study its impact on hunting, and importantly, non-hunting related firearm incidents. Design Quasi-experimental analysis using start of hunting season in United States. Setting Populations of US states with highest number of hunting accidents reported
 - 
    Ask the consultant: Stroke BMJ (IF 42.7) Pub Date : 2025-04-17 Don Sims
### What you need to know ### BMJ Learning To obtain accredited continuous professional development points, complete the full BMJ Learning module at https://new-learning.bmj.com/course/10064619. The module contains eight additional questions submitted by users of BMJ Learning, including therapeutic cooling, posterior circulation stroke, stroke recovery, and mechanical thrombectomy. Stroke physician
 - 
    Fluid intake and heart failure … and other research BMJ (IF 42.7) Pub Date : 2025-04-17 Tom Nolan
Tom Nolan reviews this week’s research It wasn’t long ago that we’d routinely. advise people with heart failure and fluid overload to restrict their fluid intake. Nowadays, restriction advice is restricted to only a few, such as those with dilutional hyponatraemia. A new multicentre, open-label trial supports this approach. It randomised 504 people with chronic heart failure attending outpatient clinics
 - 
    Tackling alcohol and unhealthy food is crucial to the health and wealth of the nation—so when will we see bolder government action? BMJ (IF 42.7) Pub Date : 2025-04-17 Zoe Rostas, Adam Briggs
Central to the government's mission to improve health and fix the NHS is a “shift from sickness to prevention.”1 Yet key indicators suggest we are moving in the wrong direction. Healthy life expectancy is declining, obesity rates are rising, health inequalities are more pronounced than ever, and economic inactivity due to ill health is at an all time high.2345 Tobacco, alcohol, and unhealthy food are
 - 
    When I use a word . . . What is a physician? BMJ (IF 42.7) Pub Date : 2025-04-17 Jeffrey K Aronson
The summaries of product characteristics (SmPCs; previously called data sheets) of certain drugs sometimes specify that they should be used “at the discretion of the physician,” often when advising about use in special groups, such as pregnant women or children. My interpretation of this at first reading was, not simply that the advice was required, but that a physician was specifically required to
 - 
    Tranexamic acid in general surgery. . . and other stories BMJ (IF 42.7) Pub Date : 2025-04-17 British Medical Journal Publishing Group
First developed in the 1960s, tranexamic acid, an inhibitor of plasminogen activation and fibrinolysis, found niche applications in treating hereditary bleeding disorders. The indications for drugs often narrow over time, but the uses of tranexamic acid have broadened. It’s now commonly used to prevent blood loss in a variety of clinical conditions. The results of a recent trial suggest it should be
 - 
    Erythematous rash in the intertriginous areas BMJ (IF 42.7) Pub Date : 2025-04-17 Shihui Zhou, Yifeng Guo
A woman in her early 60s presented with a three day history of a widespread, itchy rash. She had no relevant history and was not on any regular medications, but the rash occurred after she had worn new clothing. Examination showed symmetrical erythema, …
 - 
    Who will pay for these miraculous new medical therapies? BMJ (IF 42.7) Pub Date : 2025-04-17 Marianne Guenot
Many high risk, high reward medical therapies that use cutting edge science are proving themselves in clinical trials. But are health services ready to pay for them—and how? Marianne Guenot reports On 16 September 2024 Jimi Olaghere became the first person with sickle cell disease to reach the summit of Mount Kilimanjaro. The 39 year old could hardly believe it as he contemplated his achievement from
 - 
    Computer aided polyp detection has limited clinical efficacy BMJ (IF 42.7) Pub Date : 2025-04-17 Samantha M Linhares, Kurt S Schultz, Anne K Mongiu
Role of artificial intelligence in identifying colorectal cancer is still evolving Colorectal cancer (CRC) is the third most common cancer worldwide, often arising from precancerous adenomas.12 Therefore, adenoma detection rate (ADR) is a key quality measure for colonoscopy, with higher ADRs associated with an improved survival benefit.34 Given the importance of this metric, advancements in artificial
 - 
    Mitigating the harms of politics and industry BMJ (IF 42.7) Pub Date : 2025-04-17 Juliet Dobson
The UK population’s health is getting worse. Health inequalities are widening and obesity rates rising, particularly among children in deprived areas (doi:10.1136/bmj.q2819 doi:10.1136/bmj.r525 doi:10.1136/bmj.q2457 doi:10.1136/bmj.r593).1234 A new investigation by The BMJ explores the influence of industry on some of these trends (doi:10.1136/bmj.r667).5 The investigation finds that the advertising
 - 
    Linear Ablation and Ethanol Infusion via the Vein of Marshall and Persistent AF. JAMA (IF 55.0) Pub Date : 2025-05-20 Yuan-Yuan Pei
 - 
    Prolonged grief disorder Lancet (IF 88.5) Pub Date : 2025-04-17 Clare Killikelly DClinPsy PhD, Kirsten V Smith DClinPsy DPhil, Ningning Zhou PhD, Prof Holly G Prigerson PhD, Prof Mary-Frances O'Connor PhD, Cyrille Kossigan Kokou-Kpolou PhD, Prof Paul A Boelen PhD, Prof Andreas Maercker PhD
Prolonged grief disorder is a mental health disorder recently included in diagnostic manuals worldwide. This Review presents published research evidence in strong support for the current conceptualisation of prolonged grief disorder: a diagnosable mental health condition with core symptoms of yearning, preoccupation, or both, which is associated with symptoms of emotional pain, identity disturbances
 - 
    Safety and immunogenicity of a virus-like particle Chikungunya virus vaccine Lancet (IF 88.5) Pub Date : 2025-04-17 Ernesto T A Marques, Donald S Burke
No Abstract
 - 
    After release, another struggle: Syria's ex-detainees Lancet (IF 88.5) Pub Date : 2025-04-17 Cosette Molijn
Section snippetsAn unwelcoming realityThose who survive detention are faced with a harsh reality once outside. Many return to heavily damaged or destroyed neighbourhoods, have financial problems, and are unable to find work in Syria's devasted economy. Family members who awaited the return of their loved ones for years might expect men or sons to retake their role as breadwinners, although they often
 - 
    Humanitarians warn over assistance for mine victims Lancet (IF 88.5) Pub Date : 2025-04-17 John Zarocostas
No Abstract
 - 
    Aid cuts prompting a shift in migration policy Lancet (IF 88.5) Pub Date : 2025-04-17 Sharmila Devi
No Abstract
 - 
    My autistic meltdown: the impact of autistic sensory needs Lancet (IF 88.5) Pub Date : 2025-04-17 Mary Doherty
No Abstract
 - 
    Susan Franklin Wood Lancet (IF 88.5) Pub Date : 2025-04-17 Andrew Green
Download: Download high-res image (190KB)Download: Download full-size image
 - 
    Population health and a representative US health-care workforce Lancet (IF 88.5) Pub Date : 2025-04-17 Vincent Guilamo-Ramos, Marco Thimm-Kaiser, Adam Benzekri, Danielle McCamey
No Abstract
 - 
    Medical research funding cuts will save money and spend lives Lancet (IF 88.5) Pub Date : 2025-04-17 Cameron John Sabet
No Abstract
 - 
    Rehabilitation under fire: insights from SUMC Lancet (IF 88.5) Pub Date : 2025-04-17 Alan Friedman, Cheryl Benjamin, Iuly Treger
No Abstract
 - 
    The need for expansion of global collaborations on AI in oncology Lancet (IF 88.5) Pub Date : 2025-04-17 Qiang Liu, Chuying Huang, Ge Zhan, Yujing Guan, Shenglong Li
No Abstract
 - 
    Finalising the WHO Pandemic Agreement for a safer future Lancet (IF 88.5) Pub Date : 2025-04-17 Walid Ammar, Christopher Baggoley, Felicity Harvey, Yasmin Ali Haque, Jeremy Konyndyk, Youngmee Jee, Samba Sow, Elhadj As Sy, Theresa Tam
No Abstract
 - 
    Irrigation efficacy in CSDH surgery: the FINISH trial Lancet (IF 88.5) Pub Date : 2025-04-17 Aaron Lawson McLean
No Abstract
 - 
    Irrigation efficacy in CSDH surgery: the FINISH trial – Authors' reply Lancet (IF 88.5) Pub Date : 2025-04-17 Rahul Raj, Kimmo Lönnrot, Teppo L N Järvinen
No Abstract
 - 
    Need for VA-ECMO after heart transplantation with HOPE Lancet (IF 88.5) Pub Date : 2025-04-17 Jose Gonzalez-Costello, Snehal R Patel, Ulrich P Jorde
No Abstract
 - 
    Need for VA-ECMO after heart transplantation with HOPE – Authors' reply Lancet (IF 88.5) Pub Date : 2025-04-17 Filip Rega, Guillaume Lebreton, Göran Dellgren, Andreas Wallinder
No Abstract
 - 
    Tecovirimat for Clade I MPXV Infection in the Democratic Republic of Congo. N. Engl. J. Med. (IF 78.5) Pub Date : 2025-04-17 ,Rosine Ali,Jules Alonga,Jean-Luc Biampata,Michael Kombozi Basika,Irina Maljkovic Berry,Nella Bisento,Emily Blum,Tyler Bonnett,Katherine Cone,Ian Crozier,Richard Davey,Ali Dilu,Lori E Dodd,Iman Gulati,Dennis Hruby,Augustin Ibanda,Francis Isse,Sylva Sivasingana Kasareka,Gaby Kayembe,Richard Kojan,Esaie Kindombe Luzolo,H Clifford Lane,Leader Lawanga,Laurens Liesenborghs,Claude Shosongo Lunghe,Yves Lula
BACKGROUND Tecovirimat is available for the treatment of mpox (formerly known as monkeypox) in Europe and the United States, on the basis of findings from efficacy studies in animals and safety evaluations in healthy humans. Evidence from randomized, controlled trials of safety and efficacy in patients with mpox is lacking. METHODS We conducted a double-blind, randomized, placebo-controlled trial
 - 
    Disseminated Syphilis Caused by Two Recombining Treponema pallidum Strains. N. Engl. J. Med. (IF 78.5) Pub Date : 2025-04-17 Nicole A P Lieberman,Shah A K Mohamed Bakhash,B Ethan Nunley,Muyi Li,Brian Mau,John S Pauk,Paul Swanson,Anand Baxi,Joshua A Lieberman,Alexander L Greninger
 - 
    To B or Not to B - the Role of B-Cell Depletion in Lupus Nephritis. N. Engl. J. Med. (IF 78.5) Pub Date : 2025-04-17 Andrea Fava
 - 
    Heart Rhythm Interventions - Devil in the Details. N. Engl. J. Med. (IF 78.5) Pub Date : 2025-04-17 Jason G Andrade
 - 
    Perioperative Chemotherapy in Esophageal Cancer. Reply. N. Engl. J. Med. (IF 78.5) Pub Date : 2025-04-17 Jens Hoeppner,Claudia Schmoor,Florian Lordick
 - 
    Case 11-2025: A 79-Year-Old Woman with Cough and Weight Loss. N. Engl. J. Med. (IF 78.5) Pub Date : 2025-04-17 Leigh H Simmons,Ryan Willett,J Erika Haydu,Megan J Fitzpatrick
 - 
    Fracture Prevention with Infrequent Zoledronate in Women. N. Engl. J. Med. (IF 78.5) Pub Date : 2025-04-17 Param Darpan Sheth
 - 
    Fidanacogene Elaparvovec for Hemophilia B - A Multiyear Follow-up Study. N. Engl. J. Med. (IF 78.5) Pub Date : 2025-04-17 John E J Rasko,Benjamin J Samelson-Jones,Lindsey A George,Adam Giermasz,Jonathan M Ducore,Jerome M Teitel,Catherine E McGuinn,Katherine A High,Ype P de Jong,Amit Chhabra,Amanda O'Brien,Lynne M Smith,Ian Winburn,Jeremy Rupon
BACKGROUND Treatment with fidanacogene elaparvovec, a recombinant adeno-associated virus (AAV) vector developed for the treatment of hemophilia B, led to sustained expression of the high-activity factor IX variant (FIX-R338L, or FIX-Padua) in a phase 1-2a study. The long-term safety and efficacy of this treatment are not known. METHODS In a 12-month study, 15 participants with severe or moderately
 - 
    Prevalence of Obesity With and Without Confirmation of Excess Adiposity Among US Adults JAMA (IF 55.0) Pub Date : 2025-04-17 Ebenezer K. Aryee, Sui Zhang, Elizabeth Selvin, Michael Fang
This study compares the prevalence of obesity (assessed by body mass index only) vs obesity prevalence when excess adiposity is confirmed by waist circumference measurement or dual-energy x-ray absorptiometry in a nationally representative sample of US adults.
 - 
    All Over Again JAMA (IF 55.0) Pub Date : 2025-04-17 Lindsay Marszal
In this narrative medicine essay, a palliative care pediatrician ponders the question of whether she would pick the same career in light of the challenges of practicing medicine and garnering respect for her subspecialty.
 - 
    Psychiatry and the Make America Healthy Again Commission JAMA (IF 55.0) Pub Date : 2025-04-17 Dost Öngür
This Viewpoint discusses how psychiatry can benefit from a public commission that promulgates a reform agenda focused on improving access to care, reducing stigma, and conducting research on topics that patients and the public care about.
 - 
    NICE approves robotic surgery tools for hip and knee operations and soft tissue procedures. BMJ (IF 42.7) Pub Date : 2025-04-17 Gareth Iacobucci
 - 
    UK ruling that woman refers to biological sex "brings clarity," says government. BMJ (IF 42.7) Pub Date : 2025-04-17 Clare Dyer
 
                        











        
            
        
                京公网安备 11010802027423号